Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
FABP1 (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
FABP1 Binds free fatty acids and their coenzyme A derivatives, bilirubin, and some other small molecules in the cytoplasm. May be involved in intracellular lipid transport. Belongs to the calycin superfamily. Fatty-acid binding protein (FABP) family. Note: This description may include information from UniProtKB.
Protein type: Lipid binding protein
Cellular Component: nucleoplasm; peroxisomal matrix; apical cortex; cytosol
Molecular Function: antioxidant activity; bile acid binding; phospholipid binding; chromatin binding; drug binding; long-chain fatty acid transporter activity; fatty acid binding
Biological Process: long-chain fatty acid transport; positive regulation of cell proliferation; positive regulation of hydrolase activity; negative regulation of caspase activity; cellular lipid metabolic process; intestinal absorption; positive regulation of fatty acid beta-oxidation; negative regulation of apoptosis
Reference #:  P07148 (UniProtKB)
Alt. Names/Synonyms: FABP1; FABPL; fatty acid binding protein 1, liver; Fatty acid-binding protein 1; Fatty acid-binding protein, liver; L-FABP; Liver-type fatty acid-binding protein
Gene Symbols: FABP1
Molecular weight: 14,208 Da
Basal Isoelectric point: 6.6  Predict pI for various phosphorylation states
Protein-Specific Antibodies or siRNAs from Cell Signaling Technology® Total Proteins
Select Structure to View Below

FABP1

Protein Structure Not Found.


STRING  |  Reactome  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  RCSB PDB  |  Phospho3D  |  Phospho.ELM  |  NetworKIN  |  UCSD-Nature  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 3 K6 __MSFSGKYQLQsQE
0 1 K6 __MSFSGKYQLQsQE
0 1 K6 __MSFSGKYQLQsQE
0 5 S11-p SGKYQLQsQENFEAF
0 1 K20 ENFEAFMKAIGLPEE
0 2 K20 ENFEAFMKAIGLPEE
0 1 K20 ENFEAFMKAIGLPEE
0 1 K31 LPEELIQKGkDIKGV
0 2 K31 LPEELIQKGkDIKGV
0 1 K31 LPEELIQKGkDIKGV
0 1 K33-ac EELIQKGkDIKGVSE
0 3 K36 IQKGkDIKGVSEIVQ
0 2 K36 IQKGkDIKGVSEIVQ
0 1 K36 IQKGkDIKGVSEIVQ
0 22 K46-ac SEIVQNGkHFKFtIt
0 2 K46 SEIVQNGKHFKFtIt
0 1 K46 SEIVQNGKHFKFtIt
0 1 K49 VQNGkHFKFtItAGs
0 1 K49 VQNGkHFKFtItAGs
0 1 K49 VQNGkHFKFtItAGs
0 3 T51-p NGkHFKFtItAGsKV
0 2 T53-p kHFKFtItAGsKVIQ
0 2 A54 HFKFtItAGsKVIQN
0 2 S56-p KFtItAGsKVIQNEF
0 1 K57 FtItAGsKVIQNEFT
0 1 K57 FtItAGsKVIQNEFT
0 1 K57 FtItAGsKVIQNEFT
0 1 T64 KVIQNEFTVGEECEL
0 1 K78 LETMTGEKVKTVVQL
0 2 K80 TMTGEKVKTVVQLEG
0 3 Q84 EKVKTVVQLEGDNKL
0 2 Q84 EKVKTVVQLEGDNKL
0 1 Q84 EKVKTVVQLEGDNKL
0 2 K90 VQLEGDNKLVTTFKN
0 1 K90 VQLEGDNKLVTTFKN
0 1 K90 VQLEGDNKLVTTFKN
0 1 T94 GDNKLVTTFKNIKsV
0 3 K96 NKLVTTFKNIKsVTE
0 1 K96 NKLVTTFKNIKsVTE
0 1 K96 NKLVTTFKNIKsVTE
0 2 K99 VTTFKNIKsVTELNG
0 2 K99 VTTFKNIKsVTELNG
0 4 S100-p TTFKNIKsVTELNGD
0 12 K121-ac TLGDIVFkRISKRI_
0 1 K121 TLGDIVFKRISKRI_
0 1 K121 TLGDIVFKRISKRI_
  mouse

 
K6-ac __MNFSGkYQLQsQE
K6-ub __MNFSGkYQLQsQE
K6-sc __MNFSGkYQLQsQE
S11-p SGkYQLQsQENFEPF
K20-ac ENFEPFMkAIGLPED
K20-ub ENFEPFMkAIGLPED
K20-sc ENFEPFMkAIGLPED
K31-ac LPEDLIQkGKDIkGV
K31-ub LPEDLIQkGKDIkGV
K31-sc LPEDLIQkGKDIkGV
K33 EDLIQkGKDIkGVSE
K36-ac IQkGKDIkGVSEIVH
K36-ub IQkGKDIkGVSEIVH
K36-sc IQkGKDIkGVSEIVH
K46-ac SEIVHEGkKIkLtIt
K46-ub SEIVHEGkKIkLtIt
K46-sc SEIVHEGkKIkLtIt
K49-ac VHEGkKIkLtItyGP
K49-ub VHEGkKIkLtItyGP
K49-sc VHEGkKIkLtItyGP
T51-p EGkKIkLtItyGPkV
T53-p kKIkLtItyGPkVVR
Y54-p KIkLtItyGPkVVRN
P56 kLtItyGPkVVRNEF
K57-ac LtItyGPkVVRNEFt
K57-ub LtItyGPkVVRNEFt
K57-sc LtItyGPkVVRNEFt
T64-p kVVRNEFtLGEECEL
K78-ub LETMTGEkVkAVVkL
K80-ub TMTGEkVkAVVkLEG
K84-ac EkVkAVVkLEGDNkM
K84-ub EkVkAVVkLEGDNkM
K84-sc EkVkAVVkLEGDNkM
K90-ac VkLEGDNkMVTtFkG
K90-ub VkLEGDNkMVTtFkG
K90-sc VkLEGDNkMVTtFkG
T94-p GDNkMVTtFkGIksV
K96-ac NkMVTtFkGIksVTE
K96-ub NkMVTtFkGIksVTE
K96-sc NkMVTtFkGIksVTE
K99-ac VTtFkGIksVTELNG
K99-ub VTtFkGIksVTELNG
S100-p TtFkGIksVTELNGD
K121-ac TLGDIVYkRVSKRI_
K121-ub TLGDIVYkRVSKRI_
K121-sc TLGDIVYkRVSKRI_
  rat

 
K6 __MNFSGKYQVQsQE
K6 __MNFSGKYQVQsQE
K6 __MNFSGKYQVQsQE
S11-p SGKYQVQsQENFEPF
K20 ENFEPFMKAMGLPED
K20 ENFEPFMKAMGLPED
K20 ENFEPFMKAMGLPED
K31 LPEDLIQKGKDIKGV
K31 LPEDLIQKGKDIKGV
K31 LPEDLIQKGKDIKGV
K33 EDLIQKGKDIKGVSE
K36 IQKGKDIKGVSEIVH
K36 IQKGKDIKGVSEIVH
K36 IQKGKDIKGVSEIVH
K46 SEIVHEGKKVKLTIT
K46 SEIVHEGKKVKLTIT
K46 SEIVHEGKKVKLTIT
K49 VHEGKKVKLTITYGs
K49 VHEGKKVKLTITYGs
K49 VHEGKKVKLTITYGs
T51 EGKKVKLTITYGsKV
T53 KKVKLTITYGsKVIH
Y54 KVKLTITYGsKVIHN
S56-p KLTITYGsKVIHNEF
K57 LTITYGsKVIHNEFT
K57 LTITYGsKVIHNEFT
K57 LTITYGsKVIHNEFT
T64 KVIHNEFTLGEECEL
K78 LETMTGEKVKAVVKM
K80 TMTGEKVKAVVKMEG
K84 EKVKAVVKMEGDNKM
K84 EKVKAVVKMEGDNKM
K84 EKVKAVVKMEGDNKM
K90 VKMEGDNKMVTTFKG
K90 VKMEGDNKMVTTFKG
K90 VKMEGDNKMVTTFKG
T94 GDNKMVTTFKGIKSV
K96 NKMVTTFKGIKSVTE
K96 NKMVTTFKGIKSVTE
K96 NKMVTTFKGIKSVTE
K99 VTTFKGIKSVTEFNG
K99 VTTFKGIKSVTEFNG
S100 TTFKGIKSVTEFNGD
K121 TLGDIVYKRVSKRI_
K121 TLGDIVYKRVSKRI_
K121 TLGDIVYKRVSKRI_
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.